西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2015年
1期
125-128
,共4页
卵巢癌%宫颈癌%CT诊断
卵巢癌%宮頸癌%CT診斷
란소암%궁경암%CT진단
ovarian cancer%cervical cancer%CT diagnosis
目的：探讨CT诊断在卵巢癌和宫颈癌放射治疗前后的临床运用价值。方法：选择进行手术合并放射治疗的宫颈癌与卵巢癌患者100例，其中宫颈癌60例，卵巢癌40例。在患者进行放射治疗前后进行CT诊断，同时进行病理分期，比较CT分期与手术病理分期的差异。结果：卵巢癌患者CT检查结果显示：浆液性囊腺癌25例，黏液性囊腺癌9例，库肯勃瘤2例，卵巢未成熟畸胎瘤2例，交界性囊腺癌1例，未检出1例。FIGO分期结果显示：Ⅰ期1例，Ⅱ期11例，Ⅲ期21例，Ⅳ期6例。宫颈癌检查结果显示：鳞癌34例(低鳞20例、中鳞18例、高鳞6例)、腺癌15例、腺鳞癌11例。FIGO分期：Ⅰ期2例、Ⅱ期15例、Ⅲ期20例、Ⅳ期21例。放射治疗后CT分期与手术病理分期比较差异无统计学意义(P＞0.05)。宫颈癌CT检查时见宫颈增大，或呈不规则软组织块。卵巢癌CT特征可见增强扫描，实体部分有增强。卵巢癌可产生腹水。结论：CT检查能准确地对宫颈癌、卵巢癌患者进行分期，为治疗提供准确的病灶信息，为患者的合理治疗创造前提。
目的：探討CT診斷在卵巢癌和宮頸癌放射治療前後的臨床運用價值。方法：選擇進行手術閤併放射治療的宮頸癌與卵巢癌患者100例，其中宮頸癌60例，卵巢癌40例。在患者進行放射治療前後進行CT診斷，同時進行病理分期，比較CT分期與手術病理分期的差異。結果：卵巢癌患者CT檢查結果顯示：漿液性囊腺癌25例，黏液性囊腺癌9例，庫肯勃瘤2例，卵巢未成熟畸胎瘤2例，交界性囊腺癌1例，未檢齣1例。FIGO分期結果顯示：Ⅰ期1例，Ⅱ期11例，Ⅲ期21例，Ⅳ期6例。宮頸癌檢查結果顯示：鱗癌34例(低鱗20例、中鱗18例、高鱗6例)、腺癌15例、腺鱗癌11例。FIGO分期：Ⅰ期2例、Ⅱ期15例、Ⅲ期20例、Ⅳ期21例。放射治療後CT分期與手術病理分期比較差異無統計學意義(P＞0.05)。宮頸癌CT檢查時見宮頸增大，或呈不規則軟組織塊。卵巢癌CT特徵可見增彊掃描，實體部分有增彊。卵巢癌可產生腹水。結論：CT檢查能準確地對宮頸癌、卵巢癌患者進行分期，為治療提供準確的病竈信息，為患者的閤理治療創造前提。
목적：탐토CT진단재란소암화궁경암방사치료전후적림상운용개치。방법：선택진행수술합병방사치료적궁경암여란소암환자100례，기중궁경암60례，란소암40례。재환자진행방사치료전후진행CT진단，동시진행병리분기，비교CT분기여수술병리분기적차이。결과：란소암환자CT검사결과현시：장액성낭선암25례，점액성낭선암9례，고긍발류2례，란소미성숙기태류2례，교계성낭선암1례，미검출1례。FIGO분기결과현시：Ⅰ기1례，Ⅱ기11례，Ⅲ기21례，Ⅳ기6례。궁경암검사결과현시：린암34례(저린20례、중린18례、고린6례)、선암15례、선린암11례。FIGO분기：Ⅰ기2례、Ⅱ기15례、Ⅲ기20례、Ⅳ기21례。방사치료후CT분기여수술병리분기비교차이무통계학의의(P＞0.05)。궁경암CT검사시견궁경증대，혹정불규칙연조직괴。란소암CT특정가견증강소묘，실체부분유증강。란소암가산생복수。결론：CT검사능준학지대궁경암、란소암환자진행분기，위치료제공준학적병조신식，위환자적합리치료창조전제。
Objective: To evaluate the clinical applying value of CT diagnosis for patients with ovarian and cervical cancers before and after radiotherapy. Methods: The 100 patients with ovarian and cervical cancers under-going surgery and radiotherapy were selected as the research object, among which patients with the cervical cancer were 60 cases while the ovarian cancer 40 cases. With the cancer stages being pathologically classified, the CT diag-noses were used before and after radiotherapy to compare the differences between CT stages and surgical pathologi-cal stages. Results: The CT findings of patients with ovarian cancer: 25 cases of serous cystadenocarcinoma, 9 of mucinous cystadenocarcinoma, 2 of Krukenberg tumor, 2 of ovarian immature teratoma, 1 of borderline cystadeno-carcinoma and 1 case not detected. The results of the FIGO stages of ovarian cancer : 1 case in theⅠstage, 11 in theⅡ, 21 in the Ⅲand 6 in the Ⅳ. The outcomes of cervical cancer: 34 cases of squamous carcinoma (including 20 cases with low squamous cells, 18 with middle and 6 with high), 15 of adenocarcinoma, 11 of adenosquamous carci-noma. The results of the FIGO stages of cervical cancer: 2 cases in theⅠstage, 15 in theⅡ, 20 in the Ⅲand 21 in the Ⅳ. There was no significant difference between CT stages and surgical pathological stages after the patients under-going the radiotherapy(P>0.05). The CT diagnosis of patients with cervical cancer showed that the uterine neck were enlarged or presented by irregular soft mass(P>0.05). The CT reinforced scans for patients with ovarian cancer demonstrated that the solid parts of the ovary were enhanced and hydroperitoneums might accompany the ovarian cancer. Conclusion: The CT examination can accurately classify the stages of cervical and ovarian cancers and pre-sent the precise information of lesions to provide an essential prerequisite of reasonable treatment for patients.
